Advanced Proteome Therapeutics Corporation (APTCF) Stock Analysis
DELISTED
What happened to Advanced Proteome Therapeutics Corporation (APTCF) stock?
Advanced Proteome Therapeutics Corporation (APTCF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 0.01 means the share price is 0.01 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Advanced Proteome Therapeutics Corporation (APTCF). Advanced Proteome Therapeutics Corporation is a biotechnology company focused on developing and commercializing a platform for chemical modification of protein therapeutics. The company's technology targets antibody drug conjugates, protein conjugates, and immunomodulation.
Last analyzed: Mar 18, 2026Advanced Proteome Therapeutics Corporation (APTCF) Healthcare & Pipeline Overview
APTCF OTC Market Information
APTCF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy APTCF shares?
No. APTCF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for APTCF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before APTCF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Advanced Proteome Therapeutics Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.